MULTI-CHANNEL ACQUISITION USING INTEGRATING SPHERE
    7.
    发明公开
    MULTI-CHANNEL ACQUISITION USING INTEGRATING SPHERE 失效
    多通道检测使用球集成

    公开(公告)号:EP0775296A1

    公开(公告)日:1997-05-28

    申请号:EP96915752.0

    申请日:1996-05-13

    发明人: TOMEI, David, L.

    IPC分类号: G01J3 G01J1

    摘要: The present invention is a novel apparatus that employs an integrating sphere (62) as a source of diffused light for multiple PMTs (64). The PMTs (64) are coupled to the integrating sphere (62) to receive diffused light from the integrating sphere (62). An optional faceplate (66) may be employed at the input port of the integrating sphere (62) in order to select certain characteristics of the light according to the characteristics of the faceplate (66).

    METHODS OF IDENTIFYING POTENTIALLY THERAPEUTICALLY EFFECTIVE AGENTS AND CELL STRAINS FOR USE THEREIN
    9.
    发明公开
    METHODS OF IDENTIFYING POTENTIALLY THERAPEUTICALLY EFFECTIVE AGENTS AND CELL STRAINS FOR USE THEREIN 失效
    方法能够识别潜在的治疗性的有效手段及适宜达尔富尔细胞系

    公开(公告)号:EP0703990A1

    公开(公告)日:1996-04-03

    申请号:EP94916006.0

    申请日:1994-04-29

    发明人: TOMEI, L., David

    IPC分类号: C12N5 G01N33

    摘要: The present invention is to a method of screening agents for potential therapeutic efficacy. The method comprises exposing a cell strain that is sensitive to known apoptotic agents to said apoptotic agents and to a potential therapeutic agent. The cell strain is then cultured and cells are removed that display diminished adherence. The remaining, adherent, cells are then incubated in the presence of a proteinase to release proteinase sensitive cells. The proteinase sensitive cells are removed to yield proteinase resistant cells and the proteinase sensitive cells are counted. The proteinase resistant cells are then collected and counted. The agent is determined to have potential therapeutic efficacy if the ratio of proteinase sensitive cells to proteinase resistant cells changes relative to a control as a result of the presence of the agent.